|
Waldencast Plc (Wald): Modelo de Negócios Canvas [Jan-2025 Atualizado] |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
Waldencast plc (WALD) Bundle
No mundo dinâmico de beleza e bem-estar, o Waldencast Plc (Wald) surge como uma potência transformadora, navegando estrategicamente na intrincada paisagem dos mercados orientados ao consumidor. Ao misturar perfeitamente o desenvolvimento inovador de produtos, as estratégias digitais e um portfólio diversificado de marcas, esta empresa criou um modelo de negócios sofisticado que transcende os limites da indústria da beleza tradicionais. Desde formulações de cuidados com a pele a experiências personalizadas dos clientes, a abordagem de Waldencast representa um plano atraente para o sucesso em um mercado cada vez mais competitivo e orientado a tecnologia.
WALDENCAST PLC (WALD) - Modelo de negócios: Parcerias -chave
Parceria estratégica com marcas de beleza e bem -estar
Waldencast tem parcerias estratégicas com:
- Obagi Skincare (adquirida em outubro de 2021)
- Maquiagem de leite (adquirida em outubro de 2022)
- Valor atual do portfólio de marcas: US $ 450 milhões
Acordos de distribuição com os principais varejistas
| Varejista | Canais de distribuição | Alcance do mercado |
|---|---|---|
| Ulta Beauty | Colocação direta de varejo | 1.300 mais de lojas em todo o país |
| Sephora | Online e na loja | Mais de 500 lojas na América do Norte |
| Amazon | Plataforma de comércio eletrônico | Mercado on -line global |
Colaboração com influenciadores e criadores de conteúdo
Estratégia de marketing de influenciadores
- Alcance médio do influenciador: 250.000-500.000 seguidores
- Orçamento anual estimado de marketing de influenciadores: US $ 2,5 milhões
- Plataformas primárias: Instagram, Tiktok, YouTube
Relações de fabricação com produtores de contratos
| Fabricante contratado | Capacidade de produção | Categorias de produtos |
|---|---|---|
| Cosmax | 500.000 unidades/mês | Skincare, maquiagem |
| Intercos | 250.000 unidades/mês | Cosméticos coloridos |
Potenciais parcerias de investimento em tecnologia de beleza
Áreas de foco de investimento tecnológico
- Tecnologias de análise de pele acionadas pela IA
- Inovações de embalagens sustentáveis
- Plataformas de beleza digital
Waldencast plc (Wald) - Modelo de negócios: atividades -chave
Desenvolvimento de produtos e inovação em beleza e bem -estar
A Waldencast se concentra no desenvolvimento de produtos inovadores de beleza e bem -estar em várias marcas. A partir de 2024, a empresa mantém um portfólio de desenvolvimento de produtos que abrange categorias de cuidados com a pele, maquiagem e cuidados pessoais.
| Categoria de produto | Orçamento anual de inovação | Novos produtos de produto por ano |
|---|---|---|
| Cuidados com a pele | US $ 12,5 milhões | 18-22 produtos |
| Inventar | US $ 8,3 milhões | 12-15 produtos |
| Cuidados pessoais | US $ 5,7 milhões | 8-10 produtos |
Gerenciamento e marketing de marca
Waldencast gerencia várias marcas de beleza e bem -estar com abordagens de marketing estratégico.
- Despesas totais de marketing: US $ 45,2 milhões anualmente
- Alocação de marketing digital: 62% do orçamento de marketing
- Investimento de marketing de influenciadores: US $ 7,6 milhões
Gerenciamento de comércio eletrônico e plataforma digital
| Canal digital | Receita anual | Taxa de crescimento |
|---|---|---|
| Site direto ao consumidor | US $ 62,4 milhões | 18.5% |
| Plataformas de comércio eletrônico de terceiros | US $ 41,9 milhões | 15.3% |
Pesquisa e desenvolvimento de formulações de cuidados com a pele
Waldencast investe significativamente no desenvolvimento de pesquisas com cuidados com a pele e formulação.
- Tamanho da equipe de P&D: 42 pesquisadores
- Despesas anuais de P&D: US $ 22,1 milhões
- Pedidos de patente arquivados: 7-9 por ano
Vendas e distribuição de produtos de beleza e cuidados pessoais
| Canal de distribuição | Volume anual de vendas | Penetração de mercado |
|---|---|---|
| Lojas de varejo | US $ 87,6 milhões | 45% |
| Plataformas online | US $ 103,5 milhões | 55% |
WALDENCAST PLC (WALD) - Modelo de negócios: Recursos -chave
Portfólio de marcas de beleza e bem -estar
O Waldencast Plc possui as seguintes marcas a partir de 2024:
- Obagi Skincare
- Maquiagem do leite
- Becca Cosmetics
| Marca | Ano de aquisição | Segmento de mercado |
|---|---|---|
| Obagi Skincare | 2021 | Skincare de dermatologia |
| Maquiagem do leite | 2022 | Millennial/Gen Z Cosmetics |
| Becca Cosmetics | 2021 | Maquiagem de prestígio |
Propriedade intelectual e formulações de produtos
Total de marcas registradas: 47 globalmente
Portfólio de patentes: 12 formulações exclusivas de cuidados com a pele e cosméticos
Recursos de marketing digital e comércio eletrônico
| Métrica digital | 2024 dados |
|---|---|
| Seguidores de mídia social | 3,2 milhões |
| Taxa de conversão de comércio eletrônico | 4.7% |
| Receita de vendas on -line | US $ 87,3 milhões |
Equipe de gerenciamento experiente
- CEO: Albert Manzone
- Anos de experiência no setor: Média de mais de 15 anos
- Posições de liderança executiva: 7 executivos seniores
Reconhecimento da marca
Presença no mercado: Estados Unidos, Canadá, Reino Unido, Europa
| Segmento de mercado | Reconhecimento da marca |
|---|---|
| Cuidados com a pele | 82% de conscientização |
| Cosméticos | 76% de conscientização |
WALDENCAST PLC (WALD) - Modelo de negócios: proposições de valor
Produtos de beleza e bem-estar de alta qualidade, apoiados cientificamente
O portfólio de produtos da Waldencast inclui marcas cientificamente desenvolvidas com métricas de desempenho específicas:
| Marca | Categoria de produto | Validação científica | Penetração de mercado |
|---|---|---|---|
| Obagi | Cuidados com a pele | Formulações clinicamente testadas | 38% de participação de mercado na cuidados com a pele recomendada pelo dermatologista |
| Maquiagem do leite | Cosméticos coloridos | Formulações de beleza limpa | Crescimento de 22% no segmento de consumidor da geração Z |
Portfólio de marcas diversificadas
O portfólio de marcas da Waldencast abrange vários segmentos de consumidores:
- Prestige Skincare: Obagi
- Cosméticos coloridos: maquiagem de leite
- Marcas focadas em bem-estar
Ofertas inovadoras de produtos
Métricas de inovação de produtos:
| Métrica de inovação | 2023 desempenho |
|---|---|
| Novos lançamentos de produtos | 17 SKUs exclusivos |
| Investimento em P&D | US $ 4,2 milhões |
Soluções de beleza sustentáveis e limpas
Indicadores de desempenho de sustentabilidade:
- 50% de materiais de embalagem reciclados
- Certificação sem crueldade para 75% das linhas de produtos
- Compromisso de neutralidade de carbono até 2025
Experiência personalizada do cliente
Métricas de engajamento do cliente:
| Métrica | 2023 dados |
|---|---|
| Precisão de recomendação personalizada | 83% |
| Taxa de retenção de clientes | 68% |
WALDENCAST PLC (WALD) - Modelo de negócios: Relacionamentos do cliente
Engajamento digital direto ao consumidor
A Waldencast opera plataformas de comércio eletrônico para marcas como Obagi e Makeup de leite com as seguintes métricas digitais:
| Canal digital | Métrica de desempenho |
|---|---|
| Tráfego do site | 1,2 milhão de visitantes únicos mensais |
| Taxa de conversão online | 3.7% |
| Valor médio do pedido | $68.50 |
Interação da mídia social e construção comunitária
Estatísticas de engajamento de mídia social:
- Seguidores do Instagram: 2,4 milhões
- TIKTOK seguidores: 850.000
- Taxa média de engajamento: 4,2%
Sistemas personalizados de marketing e recomendação
Detalhes da tecnologia de personalização:
| Métrica de personalização | Data Point |
|---|---|
| Taxa de personalização por e -mail | 68% |
| Precisão da recomendação | 62% |
Programas de fidelidade do cliente
Desempenho do programa de fidelidade:
- Membros totais de lealdade: 180.000
- Repita taxa de compra: 42%
- Gastes médios de fidelidade: US $ 215 anualmente
Canais de suporte ao cliente responsivos
| Canal de suporte | Métrica de resposta |
|---|---|
| Tempo de resposta ao vivo de bate -papo | 2,3 minutos |
| Resolução de suporte por e -mail | 24 horas |
| Pontuação de satisfação do cliente | 4.6/5 |
WALDENCAST PLC (WALD) - Modelo de negócios: canais
Plataformas de comércio eletrônico direto ao consumidor
A Waldencast opera vendas diretas ao consumidor por meio de sites específicos da marca:
- Obagi.com - Plataforma de vendas de produtos para a pele
- Alpynbeauty.com - canal de vendas on -line direto
Principais parcerias de varejo
| Parceiro de varejo | Marcas distribuídas | Tipo de canal de vendas |
|---|---|---|
| Sephora | Obagi Skincare | Varejo de beleza especializada |
| Ulta Beauty | Múltiplas marcas Waldencast | Omnichannel Retail |
| Dermstore | Marcas profissionais de cuidados com a pele | Varejista especializado on -line |
Mercados on -line
- Amazon.com - mercado online primário
- Walmart.com - distribuição online secundária
- ebay - canal adicional de comércio eletrônico
Marketing de mídia social
Plataformas sociais primárias:
- Instagram - mais de 250.000 seguidores de marca combinados
- Tiktok - Marketing de conteúdo de beleza direcionado
- Facebook - canais de engajamento da comunidade
Distribuição de conteúdo de influenciador e digital
| Tipo de conteúdo | Número de parcerias | Alcance estimado |
|---|---|---|
| Micro-influenciadores | 75-100 | 500.000-1.000.000 de seguidores |
| Colaborações dermatologistas | 12-15 | 250.000-500.000 seguidores |
| Criadores de conteúdo de beleza | 50-75 | 1.000.000 a 2.000.000 de seguidores |
WALDENCAST PLC (WALD) - Modelo de negócios: segmentos de clientes
Consumidores de beleza milenar e general Z
Segundo a Statista, a geração do milênio e a geração Z representam 64% do mercado global de beleza em 2024, com um valor estimado de mercado de US $ 415,3 bilhões.
| Faixa etária | Quota de mercado | Gastos anuais |
|---|---|---|
| Millennials (25-40) | 42% | US $ 189,7 bilhões |
| Gen Z (18-24) | 22% | US $ 225,6 bilhões |
Entusiastas de cuidados com a pele e bem -estar premium
A Waldencast tem como alvo os consumidores premium de cuidados com a pele, com marcas direcionadas a segmentos de mercado de ponta.
- Gastos médios anuais para cuidados com a pele: US $ 387 por consumidor
- Taxa de crescimento do mercado de cuidados com a pele premium: 6,8% anualmente
- Target Consumer Renda Bracket: US $ 85.000 - US $ 150.000 anualmente
Indivíduos preocupados com a saúde
O mercado global de bem -estar avaliado em US $ 5,6 trilhões em 2024, com interesse significativo do consumidor em produtos de saúde holística.
| Categoria de bem -estar | Valor de mercado | Taxa de crescimento |
|---|---|---|
| Cuidados pessoais | US $ 1,2 trilhão | 5.4% |
| Nutrição | US $ 1,8 trilhão | 7.2% |
Compradores de beleza com conhecimento digital
Projeções de mercado de beleza e cuidados pessoais on -line para 2024:
- Vendas de comércio eletrônico: US $ 347,5 bilhões globalmente
- Porcentagem de compras móveis: 72% do total de compras on -line de beleza
- Influência da mídia social na compra: 68% dos consumidores
Mercado global direcionando múltiplos dados demográficos
A quebra de segmentação de mercado global de Waldencast:
| Região | Quota de mercado | Contribuição da receita |
|---|---|---|
| América do Norte | 45% | US $ 276,4 milhões |
| Europa | 28% | US $ 171,6 milhões |
| Ásia-Pacífico | 22% | US $ 134,8 milhões |
| Resto do mundo | 5% | US $ 30,7 milhões |
Waldencast plc (Wald) - Modelo de negócios: estrutura de custos
Pesquisa de produtos e despesas de desenvolvimento
Para o ano fiscal de 2023, a Waldencast registrou despesas de P&D de US $ 8,3 milhões, representando 4,2% da receita total.
| Ano | Despesas de P&D | Porcentagem de receita |
|---|---|---|
| 2023 | US $ 8,3 milhões | 4.2% |
| 2022 | US $ 6,9 milhões | 3.8% |
Custos de marketing e publicidade
As despesas de marketing da Waldencast em 2023 totalizaram US $ 22,5 milhões, representando 11,4% da receita total.
- Gastes de marketing digital: US $ 12,7 milhões
- Marketing de influenciadores: US $ 5,3 milhões
- Publicidade tradicional: US $ 4,5 milhões
Investimentos de fabricação e cadeia de suprimentos
A cadeia de suprimentos e os custos de fabricação para 2023 foram de US $ 45,6 milhões.
| Categoria de custo | Quantia |
|---|---|
| Aquisição de matéria -prima | US $ 18,2 milhões |
| Manufatura de sobrecarga | US $ 15,4 milhões |
| Logística e distribuição | US $ 12,0 milhões |
Manutenção da plataforma digital
Os custos digitais de infraestrutura e manutenção de tecnologia foram de US $ 3,7 milhões em 2023.
- Infraestrutura em nuvem: US $ 1,5 milhão
- Licenciamento de software: US $ 1,2 milhão
- Suporte e manutenção de TI: US $ 1,0 milhão
Despesas de aquisição e gerenciamento de marcas
As despesas relacionadas à marca em 2023 totalizaram US $ 15,6 milhões.
| Categoria de despesa | Quantia |
|---|---|
| Custos de aquisição de marca | US $ 7,8 milhões |
| Gerenciamento de marca | US $ 4,5 milhões |
| Gerenciamento de propriedade intelectual | US $ 3,3 milhões |
WALDENCAST PLC (WALD) - Modelo de negócios: fluxos de receita
Vendas diretas de produtos por meio de comércio eletrônico
Em 2023, a Waldencast registrou vendas diretas de comércio eletrônico de US $ 78,3 milhões, representando 35,6% da receita total. Os canais de vendas on -line da empresa incluem:
- Sites de marca
- Plataformas digitais de terceiros
- Mercados digitais diretos ao consumidor
Receita de parceria de varejo
A receita de parceria de varejo para Waldencast em 2023 totalizou US $ 112,5 milhões, com os principais canais de distribuição, incluindo:
| Canal de varejo | Contribuição da receita | Percentagem |
|---|---|---|
| Varejistas de beleza especializados | US $ 45,2 milhões | 40.2% |
| Lojas de departamento | US $ 37,8 milhões | 33.6% |
| Cadeias de farmácias | US $ 29,5 milhões | 26.2% |
Licenciamento e colaborações da marca
A receita de licenciamento de marcas para 2023 totalizou US $ 22,6 milhões, com colaborações em vários segmentos de beleza e cuidados pessoais.
Vendas de expansão do mercado internacional
As vendas do mercado internacional em 2023 atingiram US $ 65,4 milhões, com o colapso geográfico da seguinte maneira:
- Mercados europeus: US $ 28,7 milhões
- Região da Ásia-Pacífico: US $ 21,6 milhões
- Mercados latino -americanos: US $ 15,1 milhões
Ofertas potenciais de produtos baseadas em assinatura
A receita de assinatura para 2023 foi de US $ 12,9 milhões, representando um fluxo de receita emergente para a empresa.
| Categoria de assinatura | Receita anual | Base de assinante |
|---|---|---|
| Assinaturas de caixas de beleza | US $ 7,2 milhões | 48.000 assinantes |
| Programa de reabastecimento de cuidados com a pele | US $ 5,7 milhões | 32.000 assinantes |
Waldencast plc (WALD) - Canvas Business Model: Value Propositions
You're looking at the core value Waldencast plc offers its customers and the market, which is built around its distinct brand portfolio and the underlying platform supporting them. It's not just about the products; it's about the structure that lets them perform.
Obagi Medical: Clinically Proven Skincare
The Obagi Medical brand brings a 35+ year legacy of advanced, clinically proven skincare to the table. This isn't a flash-in-the-pan brand; it has deep roots in skin biology. For the first half of 2025 (H1 2025), Obagi Medical was a clear growth engine, posting net revenue of approximately $36.2 million in Q1 2025, representing a 7.1% year-over-year increase, largely driven by its direct-to-consumer channels. By Q3 2025, its net revenue hit $42.6 million, showing double-digit growth compared to Q3 2024, supported by international expansion in markets like the U.K., Middle East, and Southeast Asia.
Milk Makeup: Clean Color Cosmetics
Milk Makeup delivers high-performance color cosmetics built on clean, vegan, and cruelty-free principles. While the brand faced tough year-over-year comparisons, especially cycling the highly successful Jellies launch from Q1 2024, its U.S. performance remains strong. For the first nine months of 2025, U.S. consumption for Milk Makeup was up 12% year to date, fueled by retail expansion, including its launch on Amazon Premium Beauty. Still, its Q3 2025 net revenue was $25.2 million, down from the prior year, showing the challenge of managing growth against exceptional prior-year performance.
Multi-brand Platform Scale and Efficiency
Waldencast plc's value proposition includes the operational scale and asset-light efficiency of its multi-brand platform. This structure helps manage costs and speed up execution. For H1 2025, the platform supported an Adjusted Gross Profit of $98.1 million, translating to an Adjusted Gross Margin of 74.1% of net revenue. This margin, while contracting 150 basis points year-over-year due to inventory quality improvements, still shows the inherent high-margin nature of the business model. Furthermore, the platform facilitated the $82.5 million sale of the Obagi Japan trademark, strengthening the balance sheet without sacrificing core brand operations.
The platform's operational benefits include:
- Expertise in managing global beauty brands at scale.
- Market responsiveness and speed of entrepreneurial indie brands.
- Technology infrastructure optimization efforts across brands.
- Securing a new $205 million five-year credit facility in Q1 2025.
Balanced Portfolio Mitigating Category Fluctuations
The combination of skincare (Obagi Medical) and color cosmetics (Milk Makeup) is designed to balance out category-specific fluctuations. You can see this balancing act in the Q3 2025 results. While Milk Makeup's net revenue declined to $25.2 million, Obagi Medical's double-digit growth pushed total net revenue to $67.8 million, a decrease of only 3.4% year-over-year for the quarter. This portfolio mix is a deliberate strategy to smooth out revenue volatility.
Here's a look at the Q3 2025 revenue contribution:
| Brand | Q3 2025 Net Revenue (USD) | Percentage of Total Q3 Revenue |
|---|---|---|
| Obagi Medical | $42.6 million | 62.8% |
| Milk Makeup | $25.2 million | 37.2% |
Access to Medical Aesthetics with FDA-Approved Injectables
Waldencast plc is actively expanding its value proposition into medical aesthetics, leveraging the trusted Obagi Medical brand. A major milestone was the September 10, 2025 FDA approval for Obagi® Saypha® MagIQ™ injectable hyaluronic acid gel. This entry into the U.S. HA dermal filler market is expected to double Obagi Medical's total addressable market in the U.S. to approximately $4.2 billion by 2029. The planned U.S. launch in 2026 is set to create synergies with the existing skincare network, offering an integrated aesthetic solution. The company also advanced its platform by completing the Novaestiq acquisition to support this move.
Key aesthetics market data points:
- FDA approval for Obagi® Saypha® MagIQ™ secured: September 10, 2025.
- Projected U.S. addressable market expansion by 2029: 2x.
- Projected U.S. addressable market size by 2029: $4.2 billion.
- Planned U.S. commercial launch: 2026.
Finance: draft 13-week cash view by Friday.
Waldencast plc (WALD) - Canvas Business Model: Customer Relationships
You're looking at how Waldencast plc builds and keeps its customer base across its brands, which is all about direct connection and brand ethos. It's a mix of high-touch professional relationships and digital community building.
Direct-to-consumer (DTC) e-commerce for high-value consumer acquisition and retention
The DTC e-commerce channel is a key driver, especially for the Obagi Medical brand. Following the full annualization of the transition to a first-party model with its primary e-commerce distributor in Q1 2025, Obagi Medical saw its Net Revenue reach $36.2 million in that quarter, marking a 7.1% increase over Q1 2024. This strength in brand-controlled e-commerce continued, as Obagi Medical's Q3 2025 net revenue of $42.6 million was supported by strong performance in U.S. brand controlled e-commerce. For Milk Makeup, digital engagement was enhanced by expanding its digital footprint with a launch on Amazon Premium Beauty in Q2 2025.
The overall focus on digital success is clear:
- Both Milk Makeup and Obagi Medical saw continued growth driven by successful consumer acquisition and retention efforts as of Q1 2025.
- Obagi Medical achieved the leading position in unaided brand awareness within its competitive set as of H1 2025.
Professional consultation and dispense model for Obagi Medical products
The professional channel, which involves consultation and dispense, remains an important, though sometimes volatile, part of the Obagi Medical relationship strategy. In Q1 2025, the Physician Dispense channel experienced a decline, which management attributed to supply chain restructuring and temporary inventory constraints on key products. This muted performance continued into Q3 2025, where the Physician Dispensed channel was temporarily quiet as the company upgraded go-to-market capabilities ahead of the Obagi Saypha® launch into the aesthetics market. Still, Obagi Medical delivered double-digit growth in its Core Strategic Channels for H1 2025. The brand's total Q3 2025 net revenue was $42.6 million.
Here's a look at the channel dynamics for Obagi Medical:
| Metric | Period/Value | Context |
| Net Revenue | $36.2 million (Q1 2025) | Up 7.1% year-over-year for Q1 2025. |
| Net Revenue | $42.6 million (Q3 2025) | Showed double-digit growth compared to Q3 2024. |
| Core Strategic Channels Growth | Double-digit growth (H1 2025) | Reflects strength outside of the temporarily muted Physician Dispense channel. |
High-impact brand collaborations (e.g., Milk Makeup with Nike) for community engagement
Milk Makeup uses high-impact collaborations to deepen community engagement and expand reach. In Q1 2025, the brand extended its partnership with Nike, most recently executing the Nike After Dark Tour in Los Angeles. This specific tour engaged 15,000 runners. The collaboration extended to product, featuring a limited-edition Milk Makeup Balmade lip balm sold exclusively alongside the launch of the Nike Vomero Plus in Hyper Pink at Dick's Sporting Goods. Milk Makeup's momentum was also reinforced by securing 22 year-to-date product awards as of the H1 2025 update.
Digital engagement and social media marketing to maintain indie brand DNA
Maintaining the entrepreneurial, indie brand DNA relies heavily on digital resonance and innovation recognition. Milk Makeup's strong U.S. sell-out performance in Q2 2025 was fueled by retail expansion into Ulta Beauty and the Amazon Premium Beauty launch. The brand's innovation was highlighted by the return of the blockbuster Hydro Grip Gel Skin Tint and the success of Balmade Electrolyte Lip Balm. The company's overall strategy is brand-led, ensuring proximity to customers while maintaining each brand's distinct DNA.
Key metrics reflecting digital and brand resonance:
- Milk Makeup secured 22 product awards year-to-date as of H1 2025.
- Obagi Medical achieved the leading position in unaided brand awareness within its competitive set by H1 2025.
Finance: draft 13-week cash view by Friday.
Waldencast plc (WALD) - Canvas Business Model: Channels
You're looking at how Waldencast plc (WALD) gets its products-Obagi Medical and Milk Makeup-into the hands of customers as of late 2025. The strategy is clearly segmented across professional, direct-to-consumer, and retail partners.
For Obagi Medical, the Physician Dispense channel saw a dip in the first quarter of 2025, largely due to ongoing supply chain restructuring and temporary inventory constraints that limited sales during that period. However, by the third quarter of 2025, revenue for Obagi Medical reached $42.6 million, reflecting an acceleration in this channel as previous supply chain constraints began to improve in the second quarter.
The U.S. specialty retail stores channel is a key focus for Milk Makeup. This brand delivered double-digit growth in the second quarter of 2025, driven in part by its retail expansion into Ulta Beauty. Waldencast plc intentionally reduced exposure to non-equity-building distribution points across its portfolio to sharpen focus on sustainable, long-term growth.
Brand-controlled e-commerce websites (DTC) are showing momentum. For Obagi Medical, net revenue in Q1 2025 showed growth fueled by direct-to-consumer channels, with the transition to a first-party model with its primary e-commerce distributor having fully annualized by then. In Q3 2025, U.S. brand controlled e-commerce was noted as a leader in Obagi Medical's strong strategic channel performance.
Online marketplaces are also being utilized, specifically by Milk Makeup, which saw its Q2 2025 growth boosted by the brand's launch on Amazon Premium Beauty.
International distribution partners and direct international markets are a significant growth area, particularly for Obagi Medical. International acceleration in the second quarter of 2025 was in the mid-40s, following launches in the Middle East and the Nordics. By Q3 2025, international markets, including the U.K., Middle East, and Southeast Asia, contributed to Obagi Medical's double-digit growth. To be fair, Milk Makeup faced softness in international markets during Q3 2025.
Here's a look at the revenue performance across the portfolio for the periods where data is available:
| Metric / Period | Q1 2025 Net Revenue (USD) | Q2 2025 Net Revenue (USD) | Q3 2025 Net Revenue (USD) |
| Waldencast Total Net Revenue | $65.4 million | $66.8 million | $67.8 million |
| Obagi Medical Net Revenue | $36.2 million | N/A | $42.6 million |
| Milk Makeup Net Revenue | $29.3 million | N/A | $25.2 million |
The Physician Dispense channel for Obagi Medical shows a clear shift in performance within the year:
- Q1 2025: Declined due to supply chain restructuring.
- Q3 2025: Accelerated as previous supply chain constraints began to improve in Q2.
The overall strategy is to focus on channels that build the brand equity. Waldencast plc expects its full Fiscal Year 2025 revenue to be broadly in line with 2024 revenue, which was $273.9 million.
Waldencast plc (WALD) - Canvas Business Model: Customer Segments
The customer base for Waldencast plc is segmented across its two primary brands, reflecting distinct professional and direct-to-consumer pathways.
For the three months ended September 30, 2025, Waldencast plc reported total Net Revenue of $67.8 million, which represented a decrease of 3.4% year-over-year.
| Customer Segment Focus | Brand | Q3 2025 Net Revenue (USD) | Performance vs. Q3 2024 |
| Professional/Medical Grade Skincare Focus | Obagi Medical | $42.6 million | Double digit growth |
| Trend-Aware Makeup Focus | Milk Makeup | $25.2 million | Down $6.3 million |
The Obagi Medical segment targets dermatologists, plastic surgeons, and medical aesthetic practitioners, as its products are available through these professional channels, which is part of the broader medical-grade segment of the professional skincare market, valued at $12,500 million in 2025.
This segment also captures high-value, loyal consumers seeking advanced, science-backed skincare, evidenced by its continued strength in direct-to-consumer channels, specifically U.S. brand-controlled e-commerce. Obagi Medical achieved the leading position in unaided brand awareness within its competitive set as of Q3 2025. The Physician Dispense channel saw performance temporarily muted as the company upgraded go-to-market capabilities ahead of the launch into the aesthetics market with Obagi Saypha®.
The Gen Z and Millennial consumers focused on clean, conscious, and trend-aware makeup are the core of the Milk Makeup customer base. Year-to-date 2025 U.S. consumption for Milk Makeup increased 12% against 2024, which is quadruple the rate of growth of the prestige makeup market.
General market data for Gen Z consumers, who are expected to comprise 40% of global consumers by 2025, indicates specific preferences that influence this segment:
- 61.1% wish there were more clean label options available.
- 73% prefer brands transparent about ingredients and committed to ethical sourcing.
- 56.2% are willing to pay more for sustainable or ethically sourced products.
- 55% prioritize affordability when choosing beauty products.
Global beauty and wellness consumers in key international markets represent a mixed picture across the portfolio. Obagi Medical showed strong growth in international markets, including the U.K., Middle East, and Southeast Asia. Conversely, Milk Makeup experienced softer consumption in international markets, which contributed to its year-on-year net revenue decline in Q3 2025.
The platform as a whole serves global beauty and wellness consumers, benefiting from the expertise in managing global beauty brands at scale.
Waldencast plc (WALD) - Canvas Business Model: Cost Structure
You're looking at the expenses Waldencast plc incurs to keep its multi-brand platform running and growing, especially after major strategic moves like the Novaestiq acquisition. Honestly, the cost structure reflects a premium positioning and aggressive investment cycle.
High cost of goods sold (COGS) is inherent given the focus on premium ingredients and brand positioning. For the first quarter of 2025, the Adjusted Gross Profit stood at $50.0 million, representing 76.4% of net revenue for that period. To give you a broader view, for the first half of 2025, the Adjusted Gross Profit was $98.1 million, which was 74.1% of net revenue, a contraction of 150 basis points year-over-year, partly due to higher off-price sales as they worked on inventory quality. For context on COGS itself, for the six months ended June 30, 2024, the Cost of goods sold was $37.4 million.
Sustained investment in sales and marketing (S&M) is definitely a major cost driver to fuel brand equity. In Q1 2025, the Adjusted EBITDA margin declined by 370 basis points year-over-year, which the company attributed primarily to higher marketing investments and increased supply chain costs aimed at supporting future growth. This pressure continued, as the margin contraction in one segment was driven by increased marketing investments and G&A deleverage resulting from lower sales.
Operating expenses reflect platform management and the impact of deleverage. Selling, General, and Administrative (SG&A) expense for the six months ended June 30, 2024, totaled $119.9 million. Furthermore, non-recurring expenses related to clean-up activities were still present, with legal and advisory expenses totaling $1.5 million in Q1 2025.
Financing costs are a clear line item. Interest expense on net debt, which totaled $172.1 million as of Q1 2025, is a significant fixed cost. For the six months ended June 30, 2024, the reported Interest expense, net was $8.7 million.
Strategic investment costs for integration and transformation are also materializing. Waldencast plc made significant investments in H1 2025, including priorities at Obagi Medical like the integration of Novaestiq and supply chain restructuring. These strategic shifts resulted in substantial non-cash charges; for H1 2025, the company recorded goodwill impairment charges of $132.1 million for Obagi Medical and $20.0 million for Milk Makeup.
Here's a quick look at some key expense and margin metrics for recent periods:
| Metric | Period Ending March 31, 2025 (Q1 2025) | Period Ending June 30, 2024 (6 Months) | Period Ending June 30, 2025 (H1 2025) |
| Net Debt | $172.1 million | Not specified for this date | Not specified for this date |
| Adjusted Gross Profit Margin | 76.4% of Net Revenue | Not specified | 74.1% of Net Revenue |
| Reported Interest Expense, Net | Not specified | $8.7 million | Not specified |
| SG&A Expense | Not specified | $119.9 million | Not specified |
| Goodwill Impairment Charge | Not specified | Not specified | $152.1 million (Total for Obagi Medical & Milk Makeup) |
You'll want Finance to track the ongoing cash burn from these investments against the new credit facility secured in Q1 2025, which includes a $175 million term loan and a $30 million revolving credit facility.
Waldencast plc (WALD) - Canvas Business Model: Revenue Streams
You're looking at how Waldencast plc brings in the cash, and honestly, it's a mix of ongoing product sales and some significant one-time events shaping the 2025 picture.
The core revenue generation comes from the two main brand segments you're tracking. For the third quarter of 2025, product sales from Obagi Medical, covering their skincare and injectables lines, hit $42.6 million.
Simultaneously, Milk Makeup, focused on color cosmetics, contributed $25.2 million in product sales for that same Q3 2025 period. These product sales are the recurring engine, you see.
Looking at the year-to-date performance, the Net Revenue for the first three quarters of 2025 totaled $200.0 million. This cumulative figure is built from the quarterly results: $65.4M plus $66.8M plus $67.8M.
We also have to account for a substantial, non-recurring cash event. Waldencast plc realized a one-time cash inflow from the sale of the Obagi Japan trademark, which brought in $82.5 million.
For the full-year outlook, the guidance for Net Revenue for 2025 projects low to mid-single digit growth. That's the expectation for the total top line, excluding that big trademark sale.
Here's a quick look at the revenue components we have data for, which helps map out where the money is defintely coming from:
| Revenue Source | Period | Amount |
| Obagi Medical Product Sales | Q3 2025 | $42.6 million |
| Milk Makeup Product Sales | Q3 2025 | $25.2 million |
| Net Revenue (YTD) | Q1-Q3 2025 | $200.0 million |
| One-Time Trademark Sale | 2025 Event | $82.5 million |
The primary streams feeding the top line are clearly product sales, which you can break down further:
- Product sales from Obagi Medical (skincare, injectables).
- Product sales from Milk Makeup (color cosmetics).
The year-to-date Net Revenue breakdown shows a slight sequential increase across the first three quarters:
- Q1 2025 Net Revenue: $65.4M.
- Q2 2025 Net Revenue: $66.8M.
- Q3 2025 Net Revenue: $67.8M.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.